Neuroendocrinology of stress

Endocrinology and Metabolism Clinics of North America

Volumn 30, Issue 3, 2001, Pages 695-728

  Habib, Kamal E ^a   Gold, Philip W ^a   Chrousos, George P ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN RELEASE; HORMONAL REGULATION; HUMAN; NEUROENDOCRINOLOGY; NORADRENALIN RELEASE; PRIORITY JOURNAL; REVIEW; STRESS; TARGET ORGAN;

EID: 0034850406     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70208-5     Document Type: Article

References (123)

1. Corticotropin-releasing factor receptors: Distribution and regulation in brain, pituitary, and peripheral tissues
2. Neuromodulatory effects of corticotropin releasing factor on cerebellar Purkinje cells: An in vivo study in the cat
3. Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm, in cortisol and leptin secretion
4. Noradrenergic mechanisms in stress and anxiety. II. Clinical studies
5. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze
6. Corticotropin-releasing factor: Effects on the autonomic nervous system and visceral systems
7. Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism
8. Modulation of memory storage
9. Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: Potential clinical implications
10. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion: Potential clinical implications
11. Regulation of corticotropin-releasing hormone secretion by ACTH at different times after adrenalectomy
12. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression
13. Adrenaline, emotional arousal and memory
14. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis: The corticotropin-releasing hormone perspective
15. Reproductive placental corticotropin-releasing hormone and its clinical implications
16. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuroendocrine and target tissue-related causes
17. Stress as a medical and scientific idea and its implications
18. Stressors, stress, and neuroendocrine integration of the adaptive response: The 1997 Hans Selye Memorial Lecture
19. The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis
20. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications
21. Age and gender influence basal and stress-modulated hypothalamic-pituitary-thyroidal function in Fischer 344/N rats
22. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact
23. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats
24. EEG stability following corticotropin releasing factor in rats
25. Corticotropin-releasing factor produces increases in brain excitability and convulsive seizures in rats
26. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease
27. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects
28. Differential antagonist activity of alpha-helical corticotropin-releasing factor 9-41 in three bioassay systems
29. Anxiety and the gastrointestinal system
30. Leptin affects food intake via CRF receptor-mediated pathways
31. The role of psychosocial factors in irritable bowel syndrome
32. Corticotropin-releasing factor (CRF) receptor modulators: Progress and opportunities for new therapeutic agents
33. Corticotropin-releasing hormone produces profound anorexigenic effects in the rhesus monkey
34. The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences
35. Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress (1)
36. Corticotropin-releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs
37. Corticotropin releasing hormone: Relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency
38. Stress system abnormalities in melancholic and atypical depression: Molecular, pathophysiological, and therapeutic implications
39. Mechanism of glucocorticoid action
40. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems
41. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: Lack of effect in other rat brain regions
42. Adaptation and stress: Physiology and pathophysiology
43. Endogenous opioids contribute to gastric ulcerogenesis during stress in male Sprague-Dawley rats
44. Protective role of the sympatho-adrenal system against stress-induced gastric mucosal injury
45. CRH-1 receptor antagonism exerts antidepressant- and anxiolytic-like effects in attenuatins stress ulcerogenesis
46. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
47. Plasma neuropeptide Y in patients with major depressive disorder
48. Regulation of pituitary corticotropin-releasing hormone (CRH) receptors by CRH: Interaction with vasopressin
49. Neurobiology and clinical aspects of neuropeptide Y
50. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models
51. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood
52. Studies on the cellular localization of spinal cord substance P receptors
53. CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys
54. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man
55. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram
56. Amygdala beta-noradrenergic influences on memory storage involve cholinergic activation
57. Effects of early parenting on growth and development in a small primate
58. Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis
59. The involvement of neuropeptide Y in the antimuricide action of noradrenaline injected into the medial amygdala of olfactory bulbectomized rats
60. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa
61. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: Relation to state of nutrition, adrenal function, and intensity of depression
62. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: Enhancement of plasma ACTH and cortisol secretion in underweight patients
63. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: Potential clinical implications
64. Arginine vasopressin, stress, and memory
65. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: Brain corticoid receptor involvement
66. Cardiovascular responses to exercise in the rat: Role of corticotropin-releasing factor
67. The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: Pathophysiologic implications
68. Locus coeruleus activation by colon distention: Role of corticotropin-releasing factor and excitatory amino acids
69. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice
70. Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
71. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women
72. The use of neuropeptide challenge tests as diagnostic adjuncts in psychiatry
73. Experience with anxiety and depression treatment studies: Implications for designing irritable bowel syndrome clinical trials
74. Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus
75. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels
76. In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility
77. Human placenta and the hypothalamic-pituitary-adrenal axis
78. Childhood adversities and psychosocial disorders
79. The effect of stress on the biosynthesis of cortisol (11beta, 17alpha, 21-trihydroxy pregn-4-ene-3, 20-sione)
80. Involvement of the amygdala in memory storage: Interaction with other brain systems
81. Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression
82. Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing hormone-stimulated adrenocorticotropic hormone and cortisol secretion
83. Bone mineral density in women with depression
84. Stress and endogenous opioid peptides: A review
85. Social separation in monkeys
86. The therapeutic potential of neuropeptide Y: Analgesic, anxiolytic and antihypertensive
87. Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients
88. Physiology and pharmacology of corticotropin-releasing factor
89. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress
90. Distribution of corticotropin-releasing factor in rat brain
91. Stress-induced changes in the gastrointestinal motor system
92. Neuroimmune mechanisms of intestinal responses to stress: Role of corticotropin-releasing factor and neurotensin
93. Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation
94. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in the nonhuman primate brain
95. A syndrome produced by diverse nocuous agents
96. Forty years of stress research: Principal remaining problems and misconceptions
97. Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion
98. Electrophysiological actions of corticotropin-releasing factor in the central nervous system
99. Symptom profiles in chronic peptic ulcer disease: A detailed study of abdominal and mental symptoms
100. Receptors for corticotropin-releasing hormone in human pituitary: Binding characteristics and autoradiographic localization to immunocytochemically defined proopiomelanocortin cells
101. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
102. Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion
103. Corticotropin-releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats
104. Effects of maternal and peer separations on young monkeys
105. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study
106. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders
107. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides
108. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin
109. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
110. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus
111. Transneuronal labeling from the rat distal colon: Anatomic evidence for regulation of distal colon function by a pontine corticotropin-releasing factor system
112. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: Substrate for the co-ordination of emotional and cognitive limbs of the stress response
113. Molecular mechanisms of steroid action: A novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors
114. Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus
115. Alterations of corticotropin-releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt
116. Central nervous system pharmacology of neuropeptide Y
117. Is functional dyspepsia just a subset of the irritable bowel syndrome?
118. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain
119. Reduced neuropeptide Y concentrations in suicide brain
120. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry
121. Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy
122. Neuropeptide Y reverses corticotropin-releasing hormone-and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats